The Ultimate Guide to Methylene Blue
By Mark Sloan
EndAllDisease Publishing
Applying one of the Hippocratic oaths (“It’s far more important to know what person the disease has than what disease the person has”), in a book that could revolutionize how chronic medical complications are diagnosed and managed, Mark Sloan asserts that the sole disease is malfunctioning cells. The prolific author—including a book in which he castigates the profiteering cancer industry for much of the iatrogenesis associated with the frequently terminal condition that he contends is largely preventable—focuses on a single substance that has extremely significant therapeutic value for a myriad of applications. The Ultimate Guide to Methylene Blue presents persuasive evidence for the importance of supplanting the current domination of Western medicine’s anti-curative symptomatic care with a primary preventive approach via metabolic medicine. Supporting Sloan’s well-researched arguments is a listing of more than 200 references.
My first encounter with the substance— used primarily as a dye in the textile industry— was its surreptitious use in a fraternity house, where a small amount was sneaked into the food or drink of pledges, who would panic for fear that they were afflicted with a rare sickness once their urine turned blue (a harmless side effect). Unbeknownst to both the startled freshmen and the upperclassmen who instigated the practical joke, was that they had in their midst a product that, if used for the various purposes suggested by Sloan, likely would have safeguarded their health for much of their lives.
The author posits that genetic mutations should be considered symptoms of disease rather than causes; throughout the book, he explains how various environmental toxins, drugs, radiation and light pollution, the typically nutrient-depleted and contaminated American diet, and other harmful habits and exposures lead to mutations and other disease-promoting aberrant cellular functioning. We are the totality of the trillions of cells and bacteria in our bodies and shouldn’t be medically managed by a fragmented care as if our tissues and organs were disconnected from one another.
In one of his chapters, Sloan documents the costly and ineffective preference of modern medicine to ascribe many illnesses to genetic defects and abnormalities. While many conditions are congenital, the vast majority of diseases and disorders are environmental and caused by personal habits, many of which are inadvertent. Much of the justification for the genetic hypothesis of disease is based on the established relationship, (although somewhat weak) between kinship and risk factors. The less accepted but much more likely explanation is that family members tend to adopt habits, consume diets and have lifestyles closer to themselves than they do to strangers.
Even though methylene blue was determined to be an efficacious and safe substance in reversing disease more than a century ago, it somehow escaped the interest of holistic practitioners, much less those who are exclusively allopathic. As long ago as 1891, it was established to be an effective anti-malaria agent. Only a possible lack of supply or the ability to be administered to large populations can explain why the infestation of malaria and other parasites continue to take the lives of millions worldwide. That process is augmented when red light therapy (not elaborated in the book) is used synergistically. A powerful detoxifier, the dye should be considered among the initial treatments of infestations and infections.
The common denominator that accounts for methylene blue’s role in addressing a large number of disparate conditions—the implicit thesis of the book—is that it restores dysfunctional mitochondria (the energy source of all cells) to equilibrium. When the mitochondria cannot utilize oxygen properly, a cascade of cellular impairments follow, which can occasionally cause mutations. More specifically, the electron transport system within mitochondria is disrupted, causing both oxygen deprivation and the proliferation of free radicals within the cells. Methylene blue counteracts that scenario because it facilitates the bypassing of the blocked flow of electrons that create free-radical activity and its attendant damage to cells.
A strong antioxidant (which destroys free radicals by neutralizing rogue electrons), methylene blue promotes oxidative phosphorylation or adenosine triphosphate, which is impaired in those with fibromyalgia and other conditions characterized by extreme fatigue. It serves to overcome fatigue by oxidizing the glucose within cells into the vasodilator CO2, a process inhibited by nitric oxide and lactic acid.
Another explanation for this important property of methylene blue is that it restores the oxygen-carrying capacity of hemoglobin when hemoglobin has oxidized to form methemoglobin, which leads to tissue hypoxia and, as a result, the release of stress hormones. That inflammatory response can lead to vasoconstriction and scarring of arteries. One of the most toxic free radicals—peroxynitrite—is formed when nitric acid reacts with oxygen. By converting methemoglobin back to hemoglobin, methylene blue overcomes the consequences of hypoxia. Interestingly, without the use of lab tests, methylene blue can be used to crudely estimate whether someone is experiencing tissue hypoxia. Sloan indicates that if a drop of the dye on skin has its blue tint disappear before six hours, the person likely is oxygen deprived.
Those individuals are experiencing a lack of ATP (an enzyme present in all cells, especially those comprising muscles), resulting in a de-energized state that, via its capacity to restore proper mitochondria function, can be remedied by the administration of methylene blue. What’s far more consequential than the systems of fatigue and malaise is the oft-neglected signal that the tired individual is developing or is at risk for one or more serious illnesses.
Few will disagree that the introduction of more than one hundred thousand chemicals—many of them carcinogenic—into our environment since World War II has led to the fertile ground for millions of instances of cancer. One of Sloanʼs most valuable contributions is his novel approach to overcome this medical scourge. In contrast to the typical declaration of war on cancer cells, assaulting them with radiation and/or drugs—both of which invariably harm non-cancerous cells (sometimes mutating them) and create overall systemic trauma—Sloan describes how the use of the subject of his book can eventually transform cancerous cells back into normal cells as a result of the dye’s effectiveness in enhancing mitochondrial respiration. That function of the methylene blue similarly can reverse conditions as divergent as neurological damage, cardiovascular disease, depression, and many others that, collectively, have created an overburdened and unnecessarily costly healthcare system. One particular under-the-radar population that should be able to benefit from methylene blue is those afflicted with xenobiotic intolerances (more commonly known as multiple chemical sensitivities).
Because many individuals don’t manifest overt symptoms and their conditions can’t be diagnosed via standard testing, modern medicine has not been able to offer much guidance, much less assistance. Regrettably due to little understanding of the illness, many are considered hypochondriacs and, worse, sometimes neurotic. Without proper support, many are subjected to discrimination, ridicule, and ostracism. Unlike those with more definable and accepted illnesses, they generally lack employment and other opportunities and, as a result, essentially become environmental refugees. Other than a nutrient-dense diet and detoxifying and immune-enhancing supplements, the only means of addressing their disabling symptoms is avoidance of exposures that trigger their reactions. Frequently unable to function within mainstream society, some are forced to relocate to remote areas. Although not insufficiently investigated (there’s little interest in exploring an unrecognized condition for which a single pharmaceutical agent isn’t likely to cure or treat), most likely harmful chemical exposures cause the explosive formation of the aforementioned peroxinitrite. Astoundingly, Sloan mentions that methylene blue has been known to be a profoundly effective antidote for chemical poisoning for nearly one hundred years. In fact, many hospital emergency rooms have it available in the event of chemical poisoning when methemoglobinemia is evident.
One of the most contrarian positions advanced by Sloan involves the pathophysiology of Alzheimer’s disease and other forms of dementia. He concludes that dementias are basically manifestations of decreased mitochondrial activity and explains that they are initiated by neuron oxygen deprivation from nitric oxide. He notes that the various drugs introduced to treat Alzheimer’s haven’t been very effective because they inappropriately increase acetylcholine levels by inhibiting the enzyme that causes the substance to disintegrate. That, as he explains, is a counterproductive approach because acetylcholine raises the concentration of nitric acid, which is what slows the oxidation of glucose to CO2, thereby inhibiting the role of respiration within the cell’s energy factory. Methylene blue not only reduces acetycholine levels but also inhibits both tau neurofibrillary tangling and the formation of beta amyloid plaques around neurons, both well-established hallmarks of Alzheimer’s. This book also contains a useful discussion of a much more common malady that appears to be increasing in incidence. In documenting the effectiveness of the dye in treating depression, Sloan shows that those who use the substance can overcome “the blues.” Accordingly, he contends that many instances of mental illness assumed to be psychologically based are instead metabolic diseases.
An application of the substance with the potential to have vast public health impact is for pain relief, mostly for acute indications. With eighty million Americans using drugs to alleviate pain and communities across the country still destabilized from the opioid crisis of the last few years, there are no reasons—other than inertia and non-patentability—not to recommend a nonaddictive and relatively safe compound for this purpose.
The practical guide (regrettably, no index is included in the compact book) offers helpful suggestions on how to obtain methylene blue, proper dosing, cautions on inappropriate use, and related matters. Unfortunately, it is not particularly well-written (Sloan can make the same claim about my review), includes unnecessarily colorful (pun intended) language, has a few typos and intersperses hype with hope. Nonetheless, health-conscious individuals should recommend and promote The Ultimate Guide… until they’re blue in the face. If methylene blue ever becomes mainstream, we’ll have a far healthier nation, one that no longer has the medical system escalatingly ravaging resources.
This article appeared in Wise Traditions in Food, Farming and the Healing Arts, the quarterly journal of the Weston A. Price Foundation, Summer 2025
🖨️ Print post

Leave a Reply